COVID-19 Update: New Pfizer and Moderna Vaccine Formulations for 2024-2025
New 2024-2025 formulations of the mRNA COVID-19 vaccines manufactured by Pfizer/BioNTech (Comirnaty) and Moderna (Spikevax) that more closely target currently circulating variants have been licensed by the FDA for persons ≥12 years old and made available under FDA Emergency Use Authorizations (EUAs) for use in persons 6 months to 11 years old.
Publication Details
- Journal
- The medical letter on drugs and therapeutics/The medical letter
- Published
- 2024-09-16
- DOI
- https://doi.org/10.58347/tml.2024.1711c
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39